||
radioligandtherapie met lutetium-177-gelabeld somatostatineanaloog (verrichting)
radioligandtherapie met lutetium-177-gelabeld somatostatineanaloog
radioligandtherapie met 177Lu-gelabeld somatostatineanalogon
radioligandtherapie met somatostatineanaloog gelabeld met lutetium-177
Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog
Lutetium (177-Lu) labeled somatostatin analog therapy
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand.
Id1103661000000108
StatusPrimitive
Methodtoedienen
Using energystraling